Global Urea Cycle Disorder Treatment Market 2023-2027

PUBLISHED: July 11, 2023

PAGES: 153 Pages

DELIVERY TIME: 1-2 business days

SELECT AN OPTION

The urea cycle disorder treatment market is forecasted to grow by USD 235.5 mn during 2022-2027, accelerating at a CAGR of 3.57% during the forecast period. The report on the urea cycle disorder treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of urea cycle disorder, rising geriatric patients, and rising focus on strategic initiatives.

Technavio's urea cycle disorder treatment market is segmented as below:

By Therapy

Glycerol phenylbutyrate
Sodium phenylbutyrate
Amino acid supplements
Sodium benzoate
Others

By Route Of Administration

Oral
Injectables

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the increasing growth potential in emerging economies as one of the prime reasons driving the urea cycle disorder treatment market growth during the next few years. Also, increasing technological advancements in terms of early screening and diagnosis emerging economies and growing need for companion diagnostics is giving rise to the diagnosis and treatment of UCD will lead to sizable demand in the market.

The report on the urea cycle disorder treatment market covers the following areas:

Urea cycle disorder treatment market sizing
Urea cycle disorder treatment market forecast
Urea cycle disorder treatment market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading urea cycle disorder treatment market vendors that include Abbott Laboratories, Acer Therapeutics Inc., Aeglea BioTherapeutics Inc., Arcturus Therapeutics Holdings Inc., Bausch Health Co. Inc., Boehringer Ingelheim International GmbH, CAMP4, Dipharma SA, Eurocept B.V., Horizon Therapeutics Plc, Immedica Pharma AB, Medunik USA, Nestle SA, Orpharma Pty Ltd., Reckitt Benckiser Group Plc, Recordati S.p.A, RELIEF THERAPEUTICS Holding SA, Swedish Orphan Biovitrum AB, Synlogic Inc., and Ultragenyx Pharmaceutical Inc.. Also, the urea cycle disorder treatment market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Product Code: IRTNTR75899

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Therapy
Exhibit 06: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

4.1 Global urea cycle disorder treatment market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on global urea cycle disorder treatment market 2017 - 2021 ($ million)
4.2 Therapy Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Therapy Segment 2017 - 2021 ($ million)
4.3 Route of Administration Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Route of Administration Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Therapy

6.1 Market segments
Exhibit 30: Chart on Therapy - Market share 2022-2027 (%)
Exhibit 31: Data Table on Therapy - Market share 2022-2027 (%)
6.2 Comparison by Therapy
Exhibit 32: Chart on Comparison by Therapy
Exhibit 33: Data Table on Comparison by Therapy
6.3 Glycerol phenylbutyrate - Market size and forecast 2022-2027
Exhibit 34: Chart on Glycerol phenylbutyrate - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Glycerol phenylbutyrate - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Glycerol phenylbutyrate - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Glycerol phenylbutyrate - Year-over-year growth 2022-2027 (%)
6.4 Sodium phenylbutyrate - Market size and forecast 2022-2027
Exhibit 38: Chart on Sodium phenylbutyrate - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Sodium phenylbutyrate - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Sodium phenylbutyrate - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Sodium phenylbutyrate - Year-over-year growth 2022-2027 (%)
6.5 Amino acid supplements - Market size and forecast 2022-2027
Exhibit 42: Chart on Amino acid supplements - Market size and forecast 2022-2027 ($ million)
Exhibit 43: Data Table on Amino acid supplements - Market size and forecast 2022-2027 ($ million)
Exhibit 44: Chart on Amino acid supplements - Year-over-year growth 2022-2027 (%)
Exhibit 45: Data Table on Amino acid supplements - Year-over-year growth 2022-2027 (%)
6.6 Sodium benzoate - Market size and forecast 2022-2027
Exhibit 46: Chart on Sodium benzoate - Market size and forecast 2022-2027 ($ million)
Exhibit 47: Data Table on Sodium benzoate - Market size and forecast 2022-2027 ($ million)
Exhibit 48: Chart on Sodium benzoate - Year-over-year growth 2022-2027 (%)
Exhibit 49: Data Table on Sodium benzoate - Year-over-year growth 2022-2027 (%)
6.7 Others - Market size and forecast 2022-2027
Exhibit 50: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 51: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 52: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibit 53: Data Table on Others - Year-over-year growth 2022-2027 (%)
6.8 Market opportunity by Therapy
Exhibit 54: Market opportunity by Therapy ($ million)
Exhibit 55: Data Table on Market opportunity by Therapy ($ million)

7 Market Segmentation by Route of Administration

7.1 Market segments
Exhibit 56: Chart on Route of Administration - Market share 2022-2027 (%)
Exhibit 57: Data Table on Route of Administration - Market share 2022-2027 (%)
7.2 Comparison by Route of Administration
Exhibit 58: Chart on Comparison by Route of Administration
Exhibit 59: Data Table on Comparison by Route of Administration
7.3 Oral - Market size and forecast 2022-2027
Exhibit 60: Chart on Oral - Market size and forecast 2022-2027 ($ million)
Exhibit 61: Data Table on Oral - Market size and forecast 2022-2027 ($ million)
Exhibit 62: Chart on Oral - Year-over-year growth 2022-2027 (%)
Exhibit 63: Data Table on Oral - Year-over-year growth 2022-2027 (%)
7.4 Injectables - Market size and forecast 2022-2027
Exhibit 64: Chart on Injectables - Market size and forecast 2022-2027 ($ million)
Exhibit 65: Data Table on Injectables - Market size and forecast 2022-2027 ($ million)
Exhibit 66: Chart on Injectables - Year-over-year growth 2022-2027 (%)
Exhibit 67: Data Table on Injectables - Year-over-year growth 2022-2027 (%)
7.5 Market opportunity by Route of Administration
Exhibit 68: Market opportunity by Route of Administration ($ million)
Exhibit 69: Data Table on Market opportunity by Route of Administration ($ million)

8 Customer Landscape

8.1 Customer landscape overview
Exhibit 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
Exhibit 71: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 72: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 73: Chart on Geographic comparison
Exhibit 74: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 75: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 76: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 77: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 78: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 79: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 80: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 81: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 82: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 83: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 84: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 85: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 86: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 87: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 88: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 89: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 90: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 91: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 92: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 93: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 94: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 China - Market size and forecast 2022-2027
Exhibit 95: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 96: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 97: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 98: Data Table on China - Year-over-year growth 2022-2027 (%)
9.9 Germany - Market size and forecast 2022-2027
Exhibit 99: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 100: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 101: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 102: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.10 UK - Market size and forecast 2022-2027
Exhibit 103: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 104: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 105: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 106: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.11 Canada - Market size and forecast 2022-2027
Exhibit 107: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 108: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 109: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibit 110: Data Table on Canada - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 111: Market opportunity By Geographical Landscape ($ million)
Exhibit 112: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 113: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends

11 Vendor Landscape

11.1 Overview
11.2 Vendor landscape
Exhibit 114: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 115: Overview on factors of disruption
11.4 Industry risks
Exhibit 116: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
Exhibit 117: Vendors covered
12.2 Market positioning of vendors
Exhibit 118: Matrix on vendor position and classification
12.3 Abbott Laboratories
Exhibit 119: Abbott Laboratories - Overview
Exhibit 120: Abbott Laboratories - Business segments
Exhibit 121: Abbott Laboratories - Key news
Exhibit 122: Abbott Laboratories - Key offerings
Exhibit 123: Abbott Laboratories - Segment focus
12.4 Acer Therapeutics Inc.
Exhibit 124: Acer Therapeutics Inc. - Overview
Exhibit 125: Acer Therapeutics Inc. - Product / Service
Exhibit 126: Acer Therapeutics Inc. - Key offerings
12.5 Aeglea BioTherapeutics Inc.
Exhibit 127: Aeglea BioTherapeutics Inc. - Overview
Exhibit 128: Aeglea BioTherapeutics Inc. - Product / Service
Exhibit 129: Aeglea BioTherapeutics Inc. - Key offerings
12.6 Arcturus Therapeutics Holdings Inc.
Exhibit 130: Arcturus Therapeutics Holdings Inc. - Overview
Exhibit 131: Arcturus Therapeutics Holdings Inc. - Product / Service
Exhibit 132: Arcturus Therapeutics Holdings Inc. - Key offerings
12.7 Bausch Health Co. Inc.
Exhibit 133: Bausch Health Co. Inc. - Overview
Exhibit 134: Bausch Health Co. Inc. - Business segments
Exhibit 135: Bausch Health Co. Inc. - Key news
Exhibit 136: Bausch Health Co. Inc. - Key offerings
Exhibit 137: Bausch Health Co. Inc. - Segment focus
12.8 Boehringer Ingelheim International GmbH
Exhibit 138: Boehringer Ingelheim International GmbH - Overview
Exhibit 139: Boehringer Ingelheim International GmbH - Business segments
Exhibit 140: Boehringer Ingelheim International GmbH - Key news
Exhibit 141: Boehringer Ingelheim International GmbH - Key offerings
Exhibit 142: Boehringer Ingelheim International GmbH - Segment focus
12.9 CAMP4
Exhibit 143: CAMP4 - Overview
Exhibit 144: CAMP4 - Product / Service
Exhibit 145: CAMP4 - Key offerings
12.10 Eurocept B.V.
Exhibit 146: Eurocept B.V. - Overview
Exhibit 147: Eurocept B.V. - Product / Service
Exhibit 148: Eurocept B.V. - Key offerings
12.11 Horizon Therapeutics Plc
Exhibit 149: Horizon Therapeutics Plc - Overview
Exhibit 150: Horizon Therapeutics Plc - Business segments
Exhibit 151: Horizon Therapeutics Plc - Key news
Exhibit 152: Horizon Therapeutics Plc - Key offerings
Exhibit 153: Horizon Therapeutics Plc - Segment focus
12.12 Medunik USA
Exhibit 154: Medunik USA - Overview
Exhibit 155: Medunik USA - Product / Service
Exhibit 156: Medunik USA - Key offerings
12.13 Orpharma Pty Ltd.
Exhibit 157: Orpharma Pty Ltd. - Overview
Exhibit 158: Orpharma Pty Ltd. - Product / Service
Exhibit 159: Orpharma Pty Ltd. - Key offerings
12.14 Recordati S.p.A
Exhibit 160: Recordati S.p.A - Overview
Exhibit 161: Recordati S.p.A - Business segments
Exhibit 162: Recordati S.p.A - Key offerings
Exhibit 163: Recordati S.p.A - Segment focus
12.15 RELIEF THERAPEUTICS Holding SA
Exhibit 164: RELIEF THERAPEUTICS Holding SA - Overview
Exhibit 165: RELIEF THERAPEUTICS Holding SA - Product / Service
Exhibit 166: RELIEF THERAPEUTICS Holding SA - Key offerings
12.16 Synlogic Inc.
Exhibit 167: Synlogic Inc. - Overview
Exhibit 168: Synlogic Inc. - Product / Service
Exhibit 169: Synlogic Inc. - Key offerings
12.17 Ultragenyx Pharmaceutical Inc.
Exhibit 170: Ultragenyx Pharmaceutical Inc. - Overview
Exhibit 171: Ultragenyx Pharmaceutical Inc. - Product / Service
Exhibit 172: Ultragenyx Pharmaceutical Inc. - Key offerings

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 173: Inclusions checklist
Exhibit 174: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 175: Currency conversion rates for US$
13.4 Research methodology
Exhibit 176: Research methodology
Exhibit 177: Validation techniques employed for market sizing
Exhibit 178: Information sources
13.5 List of abbreviations
Exhibit 179: List of abbreviations

Product Code: IRTNTR75899

Exhibits:

Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Therapy
Exhibits6: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on global urea cycle disorder treatment market 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - Therapy Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - Route of Administration Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Therapy - Market share 2022-2027 (%)
Exhibits31: Data Table on Therapy - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Therapy
Exhibits33: Data Table on Comparison by Therapy
Exhibits34: Chart on Glycerol phenylbutyrate - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Glycerol phenylbutyrate - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Glycerol phenylbutyrate - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Glycerol phenylbutyrate - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Sodium phenylbutyrate - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Sodium phenylbutyrate - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Sodium phenylbutyrate - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Sodium phenylbutyrate - Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Amino acid supplements - Market size and forecast 2022-2027 ($ million)
Exhibits43: Data Table on Amino acid supplements - Market size and forecast 2022-2027 ($ million)
Exhibits44: Chart on Amino acid supplements - Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Amino acid supplements - Year-over-year growth 2022-2027 (%)
Exhibits46: Chart on Sodium benzoate - Market size and forecast 2022-2027 ($ million)
Exhibits47: Data Table on Sodium benzoate - Market size and forecast 2022-2027 ($ million)
Exhibits48: Chart on Sodium benzoate - Year-over-year growth 2022-2027 (%)
Exhibits49: Data Table on Sodium benzoate - Year-over-year growth 2022-2027 (%)
Exhibits50: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibits51: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibits52: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits53: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits54: Market opportunity by Therapy ($ million)
Exhibits55: Data Table on Market opportunity by Therapy ($ million)
Exhibits56: Chart on Route of Administration - Market share 2022-2027 (%)
Exhibits57: Data Table on Route of Administration - Market share 2022-2027 (%)
Exhibits58: Chart on Comparison by Route of Administration
Exhibits59: Data Table on Comparison by Route of Administration
Exhibits60: Chart on Oral - Market size and forecast 2022-2027 ($ million)
Exhibits61: Data Table on Oral - Market size and forecast 2022-2027 ($ million)
Exhibits62: Chart on Oral - Year-over-year growth 2022-2027 (%)
Exhibits63: Data Table on Oral - Year-over-year growth 2022-2027 (%)
Exhibits64: Chart on Injectables - Market size and forecast 2022-2027 ($ million)
Exhibits65: Data Table on Injectables - Market size and forecast 2022-2027 ($ million)
Exhibits66: Chart on Injectables - Year-over-year growth 2022-2027 (%)
Exhibits67: Data Table on Injectables - Year-over-year growth 2022-2027 (%)
Exhibits68: Market opportunity by Route of Administration ($ million)
Exhibits69: Data Table on Market opportunity by Route of Administration ($ million)
Exhibits70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits71: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits72: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits73: Chart on Geographic comparison
Exhibits74: Data Table on Geographic comparison
Exhibits75: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits76: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits77: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits100: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits101: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits103: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits104: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits105: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits106: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits107: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits108: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits109: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibits110: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibits111: Market opportunity By Geographical Landscape ($ million)
Exhibits112: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits113: Impact of drivers and challenges in 2022 and 2027
Exhibits114: Overview on Criticality of inputs and Factors of differentiation
Exhibits115: Overview on factors of disruption
Exhibits116: Impact of key risks on business
Exhibits117: Vendors covered
Exhibits118: Matrix on vendor position and classification
Exhibits119: Abbott Laboratories - Overview
Exhibits120: Abbott Laboratories - Business segments
Exhibits121: Abbott Laboratories - Key news
Exhibits122: Abbott Laboratories - Key offerings
Exhibits123: Abbott Laboratories - Segment focus
Exhibits124: Acer Therapeutics Inc. - Overview
Exhibits125: Acer Therapeutics Inc. - Product / Service
Exhibits126: Acer Therapeutics Inc. - Key offerings
Exhibits127: Aeglea BioTherapeutics Inc. - Overview
Exhibits128: Aeglea BioTherapeutics Inc. - Product / Service
Exhibits129: Aeglea BioTherapeutics Inc. - Key offerings
Exhibits130: Arcturus Therapeutics Holdings Inc. - Overview
Exhibits131: Arcturus Therapeutics Holdings Inc. - Product / Service
Exhibits132: Arcturus Therapeutics Holdings Inc. - Key offerings
Exhibits133: Bausch Health Co. Inc. - Overview
Exhibits134: Bausch Health Co. Inc. - Business segments
Exhibits135: Bausch Health Co. Inc. - Key news
Exhibits136: Bausch Health Co. Inc. - Key offerings
Exhibits137: Bausch Health Co. Inc. - Segment focus
Exhibits138: Boehringer Ingelheim International GmbH - Overview
Exhibits139: Boehringer Ingelheim International GmbH - Business segments
Exhibits140: Boehringer Ingelheim International GmbH - Key news
Exhibits141: Boehringer Ingelheim International GmbH - Key offerings
Exhibits142: Boehringer Ingelheim International GmbH - Segment focus
Exhibits143: CAMP4 - Overview
Exhibits144: CAMP4 - Product / Service
Exhibits145: CAMP4 - Key offerings
Exhibits146: Eurocept B.V. - Overview
Exhibits147: Eurocept B.V. - Product / Service
Exhibits148: Eurocept B.V. - Key offerings
Exhibits149: Horizon Therapeutics Plc - Overview
Exhibits150: Horizon Therapeutics Plc - Business segments
Exhibits151: Horizon Therapeutics Plc - Key news
Exhibits152: Horizon Therapeutics Plc - Key offerings
Exhibits153: Horizon Therapeutics Plc - Segment focus
Exhibits154: Medunik USA - Overview
Exhibits155: Medunik USA - Product / Service
Exhibits156: Medunik USA - Key offerings
Exhibits157: Orpharma Pty Ltd. - Overview
Exhibits158: Orpharma Pty Ltd. - Product / Service
Exhibits159: Orpharma Pty Ltd. - Key offerings
Exhibits160: Recordati S.p.A - Overview
Exhibits161: Recordati S.p.A - Business segments
Exhibits162: Recordati S.p.A - Key offerings
Exhibits163: Recordati S.p.A - Segment focus
Exhibits164: RELIEF THERAPEUTICS Holding SA - Overview
Exhibits165: RELIEF THERAPEUTICS Holding SA - Product / Service
Exhibits166: RELIEF THERAPEUTICS Holding SA - Key offerings
Exhibits167: Synlogic Inc. - Overview
Exhibits168: Synlogic Inc. - Product / Service
Exhibits169: Synlogic Inc. - Key offerings
Exhibits170: Ultragenyx Pharmaceutical Inc. - Overview
Exhibits171: Ultragenyx Pharmaceutical Inc. - Product / Service
Exhibits172: Ultragenyx Pharmaceutical Inc. - Key offerings
Exhibits173: Inclusions checklist
Exhibits174: Exclusions checklist
Exhibits175: Currency conversion rates for US$
Exhibits176: Research methodology
Exhibits177: Validation techniques employed for market sizing
Exhibits178: Information sources
Exhibits179: List of abbreviations